Chi Sheng Pharma & Biotech Co Ltd
TPEX:4111
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of Chi Sheng Pharma & Biotech Co Ltd (4111) under the Base Case is 38.21 TWD per share. Compared with the current market price of 27.5 TWD, the stock appears Undervalued by 28% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Chi Sheng Pharma & Biotech Does
Chi Sheng Pharma & Biotech Co., Ltd. engages in the manufacture and distribution of medical medicines and equipment. The company is headquartered in Hukou, Hsinchu. The firm provides injections, including hemodialysis concentrate, amino acid injection with electrolytes, vitamins, cephalosporin antibiotics, antihistamines and antipruritics, as well as ginkgo injections; oral preparations, including antibiotics, cold syrups and liquid antacid; external medicines, including contact lens fluid, normal saline for wash and povidone-iodine solution, and consumer goods, including functional health…
- Headquarters
- Taiwan TW
- IPO date
- Mar 6, 1999
Balance Sheet
Continue Research
Decided on Chi Sheng Pharma & Biotech? Get an email when Chi Sheng Pharma & Biotech Co Ltd reaches the price you’d buy at. Free with an account.
What is the Intrinsic Value of one Chi Sheng Pharma & Biotech Co Ltd stock?
The intrinsic value for Chi Sheng Pharma & Biotech Co Ltd (4111) under the Base Case is 38.21 TWD.
Is Chi Sheng Pharma & Biotech Co Ltd stock undervalued or overvalued?
Compared with the current market price of 27.5 TWD, the stock appears Undervalued by 28% .